For research and education only · Not reviewed by a medical professional · Disclaimer

← PepsRadar home

EXPLORE THE BIOLOGY

Peptides for Anti-Aging & Mitochondria: What the Human Evidence Shows

Content updated · how dates work

Cellular energy, stress responses, and aging research.

This topic groups related research questions. Shared biology does not make different peptides interchangeable, or establish a clinical benefit. Compare each paper’s population, preparation, and measured outcome.

Mitochondria & aging: what the human evidence shows

Each peptide is sorted by the strongest kind of human study among its profile’s selected studies, and the row shows what that study found and who was studied. A higher tier means stronger evidence exists, not that the peptide works for mitochondria & aging: the best trial may be small, negative or about a different condition. No doses.

PeptideStrongest human evidence in our sourcesFDAHuman safety data
FDA-approved medicine (1)Approved for the specific uses on its label, which may not be this goal.
ElamipretideTAZPOWER (2021) · Human crossover trial + open extension
Neither primary endpoint—six-minute walking distance or symptom score—was met in the blinded phase. Improvements appeared in the extension, with eight participants reaching 36 weeks.
Limitation: An uncontrolled extension is less reliable for attributing benefit. Read the later FDA decision separately: accelerated approval used knee-muscle strength and requires confirmation of clinical benefit.
Studied: 12 participants with Barth syndrome in the blinded phase.
FDA-approvedFDA label
Randomized human trials (2)At least one randomized or placebo-controlled trial, which may be small, negative or about another condition.
GlutathioneOral glutathione and body stores (2015) · Human randomized trial
Glutathione increased in measured blood and cellular compartments in the supplemented groups and returned toward baseline after washout.
Limitation: Biomarker changes are different from demonstrated disease prevention, improved survival, or broad “detox” benefits.
Studied: 54 nonsmoking adults.
Not approvedTrials only
L-CarnosineCarnosine in overweight and obese adults (2016) · Human randomized pilot trial
The supplemented group showed attenuation of increases in fasting insulin and insulin resistance. A subgroup analysis reported glucose-tolerance changes.
Limitation: Small pilot and subgroup findings do not establish prevention of type 2 diabetes or treatment of neurological disease.
Studied: 30 overweight or obese adults without diabetes.
Not approvedTrials only
Small or uncontrolled human studies (2)Human reports without randomization, such as pilots, case series or open-label studies.
NAD+Metabolic fate of intravenous NAD+ (2019) · Human metabolic pilot study
The investigators did not observe an initial plasma increase during the first two hours. Urinary NAD+ and methyl-nicotinamide increased over the infusion period.
Limitation: This was a metabolic-fate experiment, not a controlled clinical efficacy trial. It cannot establish anti-aging or cognitive benefit.
Studied: Human volunteers in an intravenous-infusion pilot.
Not approvedVery limited
ThymalinThymalin and Epithalamin in older adults (2003) · Human clinical report with limited abstract methods
The authors reported lower illness and mortality measures in treated groups.
Limitation: Limited accessible methods and multiple preparations prevent a strong causal interpretation. Reported associations should not be presented as proof of lifespan extension.
Studied: 266 elderly participants in a reported six-to-eight-year follow-up.
Not approvedVery limited
Animal and lab studies only (9)No human study in our sources.
5-Amino-1MQSee the profile for the animal and lab research.Not approvedNone
EpitalonSee the profile for the animal and lab research.Not approvedNone
FOXO4-DRISee the profile for the animal and lab research.Not approvedNone
HumaninSee the profile for the animal and lab research.Not approvedNone
MOTS-cSee the profile for the animal and lab research.Not approvedNone
Peptide bioregulators (Khavinson peptides)See the profile for the animal and lab research.Not approvedVery limited
PinealonSee the profile for the animal and lab research.Not approvedVery limited
PNC-27See the profile for the animal and lab research.Not approvedNone
SLU-PP-332See the profile for the animal and lab research.Not approvedNone

Selected studies, not a systematic review. Approval belongs to a specific product and use. Side-by-side comparisons: MOTS-c vs Elamipretide · Epitalon vs Pinealon (all comparisons).

5-Amino-1MQ

5-Amino-1MQ is a small molecule studied as an inhibitor of nicotinamide N-methyltransferase (NNMT). Its featured evidence concerns cultured adipocytes and obese mice, rather than demonstrated weight loss in people.

Related compounds

Read the studies →

Elamipretide

Elamipretide targets mitochondrial biology. Its approved product, Forzinity, has a specific Barth syndrome indication rather than a general anti-aging use.

Prescription medicines

Read the studies →

Epitalon

Epitalon, also spelled Epithalon, appears in telomerase and aging discussions. The selected study concerns cultured cells rather than a lifespan trial.

Research topics

Read the studies →

FOXO4-DRI

FOXO4-DRI is an experimental peptide designed to disrupt an interaction involved in senescent-cell survival. Its widely discussed aging findings come from cell and mouse experiments.

Research topics

Read the studies →

Glutathione

Glutathione is an endogenous tripeptide involved in redox biology. A six-month oral-supplement trial measured glutathione stores in several body compartments.

Research topics

Read the studies →

Humanin

Humanin emerged from experiments examining neuronal cell survival. It is a research topic in mitochondrial and neurodegenerative biology, not an established dementia treatment.

Research topics

Read the studies →

L-Carnosine

L-Carnosine is a dipeptide investigated in metabolic and cellular research. A small oral-supplement pilot examined insulin and glucose-related measures in adults without diabetes.

Research topics

Read the studies →

MOTS-c

MOTS-c is a 16-amino-acid peptide studied as a mitochondrial signal. Its metabolic research is frequently discussed alongside exercise and aging.

Research topics

Read the studies →

NAD+

NAD+ is a cofactor involved in cellular redox metabolism. A human pilot measured its metabolic fate during infusion; that experiment did not test longevity, cognition, or treatment of a disease.

Related compounds

Read the studies →

Peptide bioregulators (Khavinson peptides)

Peptide bioregulators are very short synthetic peptides, two to four amino acids long, developed by Vladimir Khavinson and colleagues in St. Petersburg. Each is named for the tissue it was proposed to support. Almost all published research on them comes from that group and its collaborators.

Research topics

Read the studies →

Pinealon

Pinealon is a tripeptide investigated in experimental stress-response biology. The selected publication concerns cells under oxidative stress, rather than a clinical memory or dementia trial.

Research topics

Read the studies →

PNC-27

PNC-27 is a laboratory peptide built from part of the p53 tumor-suppressor protein attached to a cell-penetrating sequence. It has been studied in cancer-cell cultures and animal models. It is not an approved or human-tested cancer treatment.

Research topics

Read the studies →

SLU-PP-332

SLU-PP-332 is a lab-made small molecule, not a peptide, that switches on the estrogen-related receptors involved in how muscle burns fuel. It is called an "exercise mimetic" because in mice it triggered some of the same metabolic changes as aerobic exercise. All published evidence comes from animal and cell studies.

Related compounds

Read the studies →

Thymalin

Thymalin is a thymus-derived extract or peptide mixture. An older clinical report described long-term outcomes in elderly participants, but the abstract does not establish the methods needed for a firm causal longevity claim.

Research topics

Read the studies →

See something wrong on this page? Report a mistake · Corrections

FREE PEPSRADAR ACCOUNT

We check sellers’ lab reports with the testing labs themselves.

So far 89 of the 105 lab reports we looked up matched the testing lab’s own record, and 12 did not.

A free account shows which sellers, report by report, plus daily prices, deals, Ask PepsRadar and alerts. If you want it, the PepsRadar Weekly brings new research and FDA news once a week. No dosing advice.

Create a free accountWhat members get →